Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablative Yttrium-90 Radioembolization Therapy for Non-Metastatic Renal Cell Carcinoma (ARRCC Trial)

NCT06642220 is registered in ClinicalTrials.gov with Derek W. Cool as lead sponsor.

NCT NCT06642220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06642220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablative Yttrium-90 Radioembolization Therapy for Non-Metastatic Renal Cell Carcinoma (ARRCC Trial)
Lead sponsor
Derek W. Cool
Phase
Phase 2
Overall status
Recruiting
Start date
July 9, 2025
Completion date
December 31, 2032
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radioembolization, renal cell carcinoma (rcc)